EPO Patents = 3

Forward Citations = 8

Loading Chart...

7 inventors (with patents filed for the assignee):

Nello Mainolfi (8 out of 40 patents)

Mikel P Moyer (2 out of 2 patents)

Eddine Saiah (2 out of 33 patents)

4. Robert David Matthew Pace (2 out of 2 patents)

5. Julia Vile (2 out of 2 patents)

6. Cristina Lecci (2 out of 13 patents)

7. Heather Tye (2 out of 18 patents)

8 patents: Sort by Forward Citations

1. 12264132 - 3-phosphoglycerate dehydrogenase inhibitors and uses thereof (2025-04-01),

2. 12187728 - Caffeine inhibitors of MTHFD2 and uses thereof (2025-01-07),

3. 11634412 - 3-phosphoglycerate dehydrogenase inhibitors and uses thereof (2023-04-25),

4. 11535593 - 3-phosphoglycerate dehydrogenase inhibitors and uses thereof (2022-12-27),

5. 11370792 - Caffeine inhibitors of MTHFD2 and uses thereof (2022-06-28),

6. 11091451 - SHMT inhibitors and uses thereof (2021-08-17),

7. 11014882 - 3-phosphoglycerate dehydrogenase inhibitors and uses thereof (2021-05-25),

8. 10954220 - 3-phosphoglycerate dehydrogenase inhibitors and uses thereof (2021-03-23),

Raze Therapeutics, Inc. is a bio-pharmaceutical company focused on developing novel therapies for the treatment of diseases related to inflammation and immune disorders. With a strong emphasis on research and development, the company is dedicated to bringing innovative solutions to patients in need. Visit our website to learn more about our pipeline and latest developments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

8 Patents

#243 in Cambridge, MA

#2,034 in Massachusetts

#34,918 in US

Cambridge, MA, United States of America

Raze Therapeutics, Inc.